Acclimation during space flight: Effects on human physiology

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 13, 2009, Pages 1317-1323

  Williams, David ^d   Kuipers, Andre ^b   Mukai, Chiaki ^c   Thirsk, Robert ^a  

^a CANADIAN SPACE AGENCY   (Canada)

^b European Space Agency Astronaut Corps

^c JAPAN AEROSPACE EXPLORATION AGENCY   (Japan)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCLIMATIZATION; AEROSPACE MEDICINE; AIRPORT; BODY FLUID; COSMONAUT; HUMAN; PHYSIOLOGY; REVIEW; SPACE FLIGHT; ADAPTATION; BONE DEMINERALIZATION; IMMUNE SYSTEM; MOTION SICKNESS; MUSCLE ATROPHY; PATHOPHYSIOLOGY; WEIGHTLESSNESS;

ADAPTATION, PHYSIOLOGICAL; BODY FLUIDS; BONE DEMINERALIZATION, PATHOLOGIC; HUMANS; IMMUNE SYSTEM; MOTION SICKNESS; MUSCULAR ATROPHY; SPACE FLIGHT; WEIGHTLESSNESS;

EID: 67650759549     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.090628     Document Type: Review

References (54)

1. Thirsk R, Kuipers A, Mukai C, et al. The space-flight environment: the International Space Station and beyond. CMAJ 2009;180:1216-20.
2. Bungo MW, Charles JB, Johnson PC Jr. Cardiovascular deconditioning during space flight and the use of saline as a countermeasures to orthostatic intolerance. Aviat Space Environ Med 1985;56:985-90.
3. International Space Station Medical Operations Requirements Document (ISS MORD). Washington (DC): National Aeronautics and Space Administration; 2007.
4. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998;47:395-406.
5. Boyd JL, Du B, Vaksman Z, et al. Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine. J Gravit Physiol 2007;14:P107-8.
6. Clement G. Musculo-skeletal system in space. In: Fundamentals of space medicine. Dordrecht, Netherlands: Kluwer Academic Publishers; 2003. p. 173- 204.
7. Shackelford LC. Musculoskeletal response to space flight. In: Barratt MR, Pool SL, editors. Principles of clinical medicine for space flight. New York (NY): Springer Science and Business Media; 2008. p. 293-306.
8. Buckey JC Jr. Muscle loss: approach to maintaining strength. In: Space physiology. New York (NY): Oxford University Press; 2006. p. 77-100.
9. Di Prampero PE, Narici MV, Tesch PA. Muscles in space. In: Fitton B, Battrick B, editors. A world without gravity: research in space for health and industrial processes. Paris (France): European Space Agency; 2001. p. 69-82.
10. Buckey JC. Bone loss: managing calcium and bone loss in space. In: Barratt MR, Pool SL, editors. Space physiology. New York (NY): Oxford University Press; 2006. p. 5-21.
11. Shackelford LC. Musculoskeletal response to space flight. In: Principles of clinical medicine for space flight. New York (NY): Springer Science and Business Media; 2008. p. 293-306.
12. LeBlanc A, Schneider V, Shackelford L, et al. Bone mineral and lean tissue loss after long duration space flight. J Musculoskeletal Neuronal Interact 2000;1:157-60.
13. Heer M. Nutritional interventions related to bone turnover in European space missions and simulation models. Nutrition 2002;18:853-6.
14. Clement G. Musculo-skeletal system in space. In: Fundamentals of space medicine. Dordrecht, Netherlands: Kluwer Academic Publishers; 2003. p. 173- 204.
15. Lang T, LeBlanc A, Evans H, et al. Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. J Bone Miner Res 2006;19:1006-12.
16. Johnston RS, Dietlein LF, Berry CA, editors. Biomedical Results of APOLLO. Washington (DC): National Aeronautics and Space Administration; 1975.
17. Cann C. Response of the skeletal system to spaceflight. In: Churchill SE, editor. Fundamentals of space lifesciences. Vol. 1. Malabar (FL): Krieger publishing company; 1997. p. 83-103.
18. Mehta SK, Crucian B, Pierson DL, et al. Monitoring immune system function and reactivation of latent viruses in the Artificial Gravity Pilot Study. J Gravit Physiol 2007;14:P21-5.
19. Kulkarni A, Yamauchi K, Sundaresan A, et al. An evidence based countermeasure for space flight: nutritional nucleotide augmentation of immunity. Proceedings of the 56th International Astronautical Congress; 2005 Oct. 17-21; Fukuoka, Japan.
20. Levine BD, Zuckerman JH, Pawelcyzk JA. Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance. Circulation 1997;96: 517-25.
21. Levine BD, Pawelcyzk JA, Ertl AC, et al. Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight. J Physiol 2002;538:331-40.
22. Charles JB, Lathers CM. Cardiovascular adaptation to spaceflight. J Clin Pharmacol 1991;31:1010-23.
23. Leach CS, Inners LD, Charles JB. Changes in total body water during space flight. J Clin Pharmacol 1991;31:1001-6.
24. Guell A. Countermeasures: extending manned spaceflight. Acta Astronaut 1995; 35:271-80.
25. Buckey JC. Effect of spaceflight on the cardiovascular system. Space physiology. New York (NY): Oxford University Press; 2006. p. 149-54.
26. Michel EL, Rummel JA, Sawin CF, et al. Results of Skylab Medical Experiment M171- Metabolic activity. In: Johnston RS, Dietlein LF, editors. Biomedical results from Skylab. Washington (DC): National Aeronautics and Space Administration; 1977. p. 372-87.
27. Heer M, Paloski WH. Space motion sickness: incidence, etiology, and countermeasures. Auton Neurosci 2006;129:77-9. Epub 2006 Aug. 28.
28. Lakin WD, Stevens SA, Penar PL. Modeling intracranial pressures in microgravity: the influence of the blood-brain barrier. Aviat Space Environ Med 2007;78: 932-6.
29. Muth ER. Motion and space sickness: intestinal and autonomic correlates. Auton Neurosci 2006;129:58-66. Epub 2006 Sep. 6.
30. Young LR. Vestibular reactions to spaceflight: human factors issues. Aviat Space Environ Med 2000;71(Suppl 9):A100-4.
31. Hawkey A. The physical price of a ticket into space. J Br Interplanet Soc 2003;56: 152-9.
32. Williams DR. The biomedical challenges of space flight. Annu Rev Med 2003;54: 245-56.
33. Cancedda R. The skeletal system. In: Fitton B, Battrick B, editors. A world without gravity: research in space for health and industrial processes. Paris (France): European Space Agency; 2001. p. 83-92.
34. Lang TF, LeBlanc AD, Evans HJ, et al. Adaptation of the proximal femur to skeletal reloading after long-duration spaceflight. J Bone Miner Res 2006;21:1224-30.
35. Musson DM, Helmreich RL. Long-term personality data collection in support of spaceflight and analogue research. Aviat Space Environ Med 2005;76(Suppl): B119-25.
36. Kanas N, Salnitskiy V, Grund EM, et al. Human interactions in space: results from Shuttle/Mir. Acta Astronaut 2001;49:243-60.
37. Collins DL. Psychological issues relevant to astronaut selection for long-duration space flight: a review of the literature. Hum Perf Extrem Environ 2003;7:43-67.
38. Dion KL. Interpersonal and group processes in long-term spaceflight crews: perspectives from social and organizational psychology. Aviat Space Environ Med 2004;75(Suppl 7):C36-43.
39. Ritsher JB, Ihle EC, Kanas N. Positive psychological effects of space missions. Acta Astronaut 2005;57:630-3.
40. Bessone L, Coffey E, Inoue N, et al. International Space Station Human Behavior & Performance Competency Model. Vol. 1. Washington (DC): National Aeronautics and Space Administration; 2008. Available: http://ston.jsc.nasa.gov/collections/TRS/-techrep/TM-2008-214775Vol1.pdf (accessed 2009 Apr. 8).
41. Bessone L, Coffey E, Filippova N, et al. International Space Station Human Behavior & Performance Competency Model. Vol. 2. Washington (DC): National Aeronautics and Space Administration; 2008. Available: http://ston.jsc.nasa.gov/collections/TRS/-techrep/TM-2008-214775Vol2.pdf (accessed 2009 Apr. 8).
42. Manzey D. Human missions to Mars: new psychological challenges and research issues. Acta Astronaut 2004;55:781-90.
43. Hawkins W, Zieglschmid J. Clinical aspects of crew health. In: Johnston R, Dietlein L, Berry C, editors. Biomedical results of Apollo. Washington (DC): National Aeronautics and Space Administration; 1975. p. 43-81.
44. Kimzey SL. Hematology and immunology studies. In: Johnson RS, Dietlein LF, editors. Biomedical results from Skylab. Washington (DC): National Aeronautics and Space Administration; 1977. p. 248-82.
45. Mehta SK, Stowe RP, Feiveson AH, et al. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight. J Infect Dis 2000;182:1761-4.
46. Pierson DL, Stowe RP, Phillips TM, et al. Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun 2005;19:235-42.
47. Mehta SK, Cohrs RJ, Forghani B, et al. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 2004;72:174-9.
48. Gmunder FK, Konstantinova I, Cogoli A, et al. Cellular immunity in cosmonauts during long duration spaceflight on board the orbital MIR station. Aviat Space Environ Med 1994;65:419-23.
49. Crucian B.. Risk of crew adverse health event due to altered immune response. In: Human Research Program Evidence Book. Washington (DC): National Aeronautics and Space Administration; 2008.
50. Boonyaratanakornkit JB, Cogoli A, Li CF, et al. Key gravity-sensitive signaling pathways drive T-cell activation. FASEB J 2005;19:2020-2. Epub 2005 Oct. 6.
51. Lewis ML, Reynolds JL, Cubano LA, et al. Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat). FASEB J 1998;12:1007-18.
52. Hughes-Fulford M. Function of the cytoskeleton in gravisensing during spaceflight. Adv Space Res 2003;32:1585-93.
53. Wilson JW, Ott CM, Höner zu Bentrup K, et al. Spaceflight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci U S A 2007;104:16299-304.
54. Borchers AT, Keen CL, Gershwin ME. Microgravity and immune responsiveness: implications for space travel. Nutrition 2002;18:889-98.